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Introduction
Epilepsy has been associated with poor health-related quality of life (HRQoL) worldwide [1] [2] [3] [4] [5] [6] . In most studies assessing HRQoL, patients have been surveyed regarding their syndromic diagnosis, duration and severity of the disease, type of treatment, and social and cultural features. Though useful for epidemiologic purposes, this approach provides limited information regarding treatment strategy of selected populations or decision-making in individual cases.
Prognostic models using multivariate analysis are statistical models that combine two or more variables of patient's data to predict clinical outcome [7] . Multivariate analysis may be particularly useful to predict HRQoL in patients with epilepsy [3, 4] , controlling for the several sources of potential confounding bias that may interfere with interpretation of the final scores of instruments for HRQoL determination [4] .
Management of epilepsy is directed towards restoring HRQoL to acceptable levels [3] . Over the years, good seizure control with low side effects has been recognized as an important aspect of HRQoL. More recently, psychosocial variables, in particular, psychiatric symptoms [2, 4, 8, 9] , have gained more attention from epileptologists and neurologists [3, 4, 10] because of the increasing recognition of their role in HRQoL.
Twenty percent of patients with epilepsy have seizures that are medically intractable, and mesial temporal lobe epilepsy related to hippocampal sclerosis (MTLE-HS) is the most common form of surgically remediable epileptic syndrome [11, 12] . The clinical, radiological, electrophysiological, psychiatric, neuropsychological and neuropathological characteristics of this syndrome have been relatively well defined, but independent determinants of HRQoL of these patients remain to be identified. Better understanding of pre-surgical HRQoL determinants in patients with refractory MTLE-HS may provide important insight into the prognosis, influencing decision-making and post-operative followup. Here, we investigated the independent association between presurgical variables and the total score of the Quality of Life in Epilepsy Inventory-31 (QOLIE-31) [1, 5] as well as the scores of each of the seven subscales composing the QOLIE-31.
Methods

Patients
Eighty-one adult consecutive patients with refractory MTLE-HS were enrolled. All underwent pre-surgical evaluation at the Centro de Epilepsia de Santa Catarina (CEPESC) between October 2008 and December 2011.
Refractoriness was defined as failure to respond to at least 2 antiepileptic drugs in adequate trials [13] , with patients showing seizures impairing awareness occurring at least once a month.
All patients had complete medical history, seizure semiology, neurological examination, psychiatric and neuropsychological evaluation, interictal and ictal video-EEG analyses, and MRI results consistent with MTLE-HS [14] [15] [16] [17] [18] [19] .
The clinical picture consisted of complex partial seizures with epigastric, autonomic, or psychic auras; focal slowing, interictal spikes, and sharp waves over the anterior, inferior, and mesial temporal regions on interictal scalp EEG; and hippocampal atrophy on T1 and increased hippocampal signal on T2 MRI sequences. We also included patients without an aura, with normal routine EEGs or bilateral interictal spikes, or with bilateral hippocampal atrophy on MRI.
Histopathology confirmed hippocampus sclerosis in 48 surgically treated patients. We excluded patients with extrahippocampal lesions, focal motor-sensory abnormalities on physical examination, generalized or extratemporal interictal spikes and marked cognitive impairment on neuropsychological testing because such features place the diagnosis of MTLE in doubt [14] [15] [16] [17] [18] [19] . Patients presenting with acute psychotic symptoms during evaluation were also excluded from the study.
The clinical characteristics analyzed were sex, age, age of epilepsy onset (recurrent seizures), duration of epilepsy, years of education, positive history for an initial precipitant injury (IPI), epilepsy duration until the pre-surgical evaluation, positive family history of seizures in firstdegree relatives, monthly complex partial seizure frequency impairing awareness in the year before the cognitive evaluation, and side of mesial temporal abnormality. Patients were considered to be under monotherapy if they were using only one AED. Patients using one AED and benzodiazepines (BDZs) were classified in the group of monotherapy plus BDZs. Patients using two or more AEDs, associated or not with BDZs, were classified as being under polytherapy. The AEDs used were phenytoin, carbamazepine, phenobarbital, or valproate. The BDZs used were clobazam or clonazepam. The video-EEG (VEEG) recording (Bio-logic, System Corp.) was done using scalp electrodes according to the international 10/20 system associated with temporal 10/10 system. Visual interictal analysis was assessed in a one-hour sleep sample (between 5:00 and 7:00 a.m.) and one-hour sample during wakefulness (between 8:00 and 10:00 a.m.) in the first, second and third days of VEEG monitoring. The patients had a mean of 4 seizures (±2.5) during the investigation. The local Research Ethics Committee approved the study, and informed consent was obtained from all patients.
Psychiatric evaluation
All patients were assessed by an experienced psychiatrist with expertise in psychiatric comorbidities associated with epilepsy (RG) as previously described [14, 20] . The psychiatric interviews were blind for QOL and lasted for about 90 to 120 minutes. All patients were interviewed alone and thereafter along with the caregiver. Present (current) and past (lifetime) axis I disorders were diagnosed according to the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders 4th edition -DSM-IV -Axis I Disorders, Clinical Version (SCID I) [21, 22] . All the diagnoses were re-allocated into three main groups: 1) depressive disorders; 2) anxiety disorders; and 3) psychotic disorders. In addition, we also considered three psychiatric comorbidities specifically associated with epilepsy as described by the ILAE Commission on Psychobiology: interictal dysphoric disorder (IDD); postictal psychosis (PIP); and interictal psychosis (IIP) [24] . Interictal dysphoric disorder was allocated into the depressive disorders group. Postictal psychosis and IIP were allocated into the psychotic disorders group. Axis II Personality Disorders (PD) were classified according to the DSM-IV [23] . We also have considered a specific Axis II PD associated with epilepsy, termed the Gastaut-Geschwind syndrome (GGS) [24] , which was classified as "other personality disorders" into Axis II from DSM-IV.
The patients were allocated into the following major diagnostic groups: current axis I: 0 = no diagnosis; 1 = anxiety disorders; 2 = depressive disorders. Past axis I: 0 = no diagnosis; 1 = anxiety disorders; 2 = depressive disorders; 3 = psychotic disorders. According to axis II, the diagnosis of the patients was defined as: 0 = no diagnosis; 1 = personality disorders.
Quality-of-life evaluation
Quality of life was assessed during the pre-surgical evaluation with a Brazilian version of QOLIE-31 that shows a good reliability, validity, and construct validity [1] . The QOLIE-31 is a widely adopted epilepsyspecific QOL instrument [25] . It comprises 30 items divided into seven subscale domains: seizure worry (5 items); emotional well-being (5 items); energy/fatigue (4 items); cognitive functioning (6 items); medication effects (3 items); overall quality of life (2 items) and social function (5 items). Each domain was scored by calculating the mean score of responses within that domain. The raw scores were converted to "0 to 100", with higher scores reflecting better QOL. Total and subscale scores were calculated according to the QOLIE-31 scoring manual [5] .
Statistical analysis
A univariate analysis was done to investigate the association between the patients' overall QOLIE-31 scores as well as each of the seven subscale domains (dependent variables) and their clinical, demographic, neuroradiologic, and psychiatric variables (independent variables). The differences between the QOLIE-31 scores and the categorical variables were determined by Mann-Whitney test or Kruskall-Wallis test due to the relatively high asymmetry of the sample sizes in the categories. Because the QOLIE-31 score and the subscale domains showed a normal distribution (Kolmogorov-Smirnov test), their association with the independent clinical, demographic, neuroradiologic, and psychiatric variables was investigated by linear regression. The independent variables that showed an association with the QOLIE-31 score and the subscale domains (dependent variables) in the univariate analysis with a "p" level of significance lower than 0.20 were included in a multiple linear regression analysis. This analysis was done to identify the clinical, demographic, neuroradiologic, and psychiatric variables that could be considered as good predictors for the overall QOLIE-31 as well as each of the seven subscale domains. In this analysis, the independent continuous variables were considered covariates. Categorical variables were included in the model and classified as 0 or 1 (for dichotomous categories) and 0, 1 or 2 for those showing 3 categories. The B coefficient (B), R coefficient (R) and R square (R squ) of the final model that better explained the overall QOLIE-31 score and the subscale domains were determined. We did not adjust for multiple tests in order to avoid a type II error [26] , and a "p" level lower than 0.05 was considered significant. Variables with clinical plausibility showing an association with a "p" level of significance lower than 0.10 were maintained in the final model. The analysis was done with the software package SPSS 17.0 (Chicago, IL, USA). Table 1 shows the correlations between the QOLIE-31 (overall score and its subscale domains) and the clinical, demographic, radiologic, and Table 1 ). Table 2 shows the multiple linear regression that better explained the independent associations among the overall QOLIE-31 score and its subscale domains of the patients with MTLE, with the clinical, demographic, radiologic, and psychiatric variables. The regression model showed that 36% of the overall score of the QOLIE-31 variance is explained by history of IPI, family history of epilepsy, disease duration, age of epilepsy onset, seizure frequency and axis II diagnosis. The final model including these variables showed a moderately strong R coefficient (0.66) for an independent negative linear relationship with the overall QOLIE-31 score. When the subscale domains were investigated, the final model of the linear regression analysis showed a moderately strong linear correlation for emotional well-being (R coefficient = 0.61) and energy/fatigue (R coefficient= 0.65). The regression models showed a fair linear correlation between the variables retained in the models and seizure worry (R coefficient = 0.31), overall QOL (R coefficient=0.43), cognitive function (R coefficient=0.39), medication effects (R coefficient = 0.30) and social function (R coefficient = 0.42).
Results
The variance of the QOLIE-31 subscales explained by their respective regression models was: 7% for seizure worry (R coefficient= 0.31), 11% for overall QOL (R coefficient= 0.43), 32% for emotional well-being (R coefficient= 0.61), 38% for energy/fatigue (R coefficient= 0.65), 13% for cognitive function (R coefficient= 0.39), 7% for medication effects (R coefficient=0.30), and 13% for social function (R coefficient=0.42) (see Table 2 ).
Discussion
We have demonstrated a moderately strong negative linear correlation between history of IPI, family history of epilepsy in first-degree relatives, disease duration, age of epilepsy onset, seizure frequency, personality disorder and the HRQoL of patients with refractory MTLE-HS. Together, these variables can explain only 36% of the overall QOLIE-31 score variance, suggesting that other non-investigated variables may be associated or may have contributed to the HRQoL in this specific subset of patients. Furthermore, when the subscale domains of the QOLIE-31 are analyzed, the combination of the investigated variables predicted lower than 15% of the score variance in 5 of 7 subscale domains investigated.
Our inclusion criteria were restricted to refractory MTLE-HS; however, there are evident similarities among our findings and those observed in patients with other types of epilepsy. In our sample, as in Taylor et al. [4] , age, gender and marital status were not independently associated with HRQoL determined by QOLIE-31 overall score or its subscale domains.
Seizure frequency, the most commonly reported predictor of negative HRQoL [4] , also showed a negative impact on the QOLIE-31 overall score in our patients. Disease duration and age of epilepsy onset were also negatively associated with the QOLIE-31 overall score in our patients, but these findings have been demonstrated to be inconsistent in the literature [4] .
The importance of medication use in HRQoL is also not clearly established in the literature [4] , and we did not find associations between the overall score of the QOLIE-31 as well as the subscale domain medication effects and the number of AEDs. It is noteworthy, however, to consider that all patients were taking high doses of AEDs, even in monotherapy. The hippocampus sclerosis was bilateral and symmetric in 2 cases and asymmetric in four cases (worse atrophy in the right side in 2 patients and in the left side in other 2). c Axis II diagnosis: no = absence of personality disorder and yes = presence of personality disorder. d The "p" levels of significance were determined by student "t" test, ANOVA or Pearson's correlation test. Still considering the QOLIE-31 overall score, we identified a relatively strong independent negative association (B coefficient: −12.1) with positive history of IPI. Initial precipitant injury was clearly documented in 65% of the patients; mean age of 4.7 (±2.5) years (data not shown). The IPI predicted the QOLIE-31 through its negative influence on emotional-well being, energy/fatigue and social function sub-scales. We are not able to explain this association but considering the relatively high level of significance and its association with 3 subscales of QOLIE-31 domains, we believe that the possibility of type I error is minimized, although not completely excluded.
The family history (first degree) of epilepsy and presence of personality disorder also predicted negatively the QOLIE-31 overall score, but their B coefficient were respectively − 7.8 and − 4.4 in comparison to that observed for the history of IPI occurrence. Both these variables may have an important psychosocial impact on the patient's life. In fact, in our clinical practice, patients became sad when they inadvertently watch themselves having an epileptic seizure in a video recorded by their family. We speculate that living with a close relative who also has epilepsy might change the patient's perception regarding the disease.
The individual analysis of QOLIE-31 subscales demonstrated the specificity and weight of each investigated variable to predict each HRQoL domain. We cannot exclude that some of the observed association may result by chance due to multiple comparisons [26] ; however, the use of a more stringent level of significance should minimize the type I error. The possibility of a confounding bias due to a co-segregation of another non-controlled variable also cannot be excluded completely. Although the search for a biological plausibility for an observed association may help to minimize the occurrence of confounding bias, this is not an easy task for a complex variable like HRQoL.
Cultural differences may also explain some particularities in HRQoL and probably the literature conflicts. We compared the QOLIE-31 results of patients with refractory MTLE-HS from the Epilepsy Section of Escola Paulista de Medicina (São Paulo Group) [1] . The QOLIE-31 subscale results were almost similar in both groups except for the seizure worry subscale which was four times lower in our patients, suggesting a clear difference in the seizure worry between the two Brazilian samples of refractory MTLE-HS.
Psychiatric symptoms and psychological state may influence the HRQoL of patients with non-neurological [27, 28] and neurological [29] [30] [31] chronic diseases, including epilepsy [3, 8] . In the present work, the occurrence of axis II PD was independently associated with a negative overall QOLIE-31 score as well as the subscale domains overall QOL, emotional well-being, energy/fatigue and social function. Although the PD subtypes have not been described in detail in the Results, the most common PD diagnosis was GGS (7 patients), histrionic (4), passiveaggressive (2), avoidant (2) , and borderline PD (1). The explanation for the association between overall or subscale domains of QOLIE-31 and PD diagnosis remains unknown, probably, in part, due to the heterogeneity of PD symptoms. However, one common characteristic to all the PD subtypes would be the presence of impaired functioning, mainly in social activities. In traumatic brain injury survivors, we demonstrated that HRQoL may be differently affected by the occurrence of personality disorders [29] . The association between HRQoL and occurrence of personality disorders in patients with epilepsy deserves further investigation. In the present work, the analysis of QOLIE-31 subscale domains showed that depressive disorders were negatively associated with emotional well-being and energy/fatigue in our patients. The self-report of depressive symptoms in Beck Depression Inventory-II (BDI-II) has been proved to be an independent predictor of HRQoL in patients with refractory epilepsy. Interestingly, the BDI-II remains independently associated with lower QOLIE-31 scores even in the sub-group of patients without depressive symptoms (BDI-II score b 10) [3, 8] , suggesting the higher sensitivity of BDI-II to predict the QOLIE-31 than a psychiatric diagnosis based on the SCID I. Among the 6 variables independently associated with the QOLIE-31 in patients with refractory MTLE-HS, only seizure frequency is potentially treatable, and surgery has been demonstrated to be effective in an observational, randomized study [12] .
The main positive aspects of our study are: i) the consecutive patient selection; ii) the well-defined population; iii) multivariate data analysis; iv) a detailed psychiatric diagnosis concurrent with the HRQoL determination. The reader should be aware of the following limitations: i) the relatively small sample size that may result in low statistical power; ii) adequate sample size that was not calculated; iii) the covariates that were not included on the basis of their theoretical confounding or prognostic influence [2] ; iv) all patients were recruited from only one epilepsy center.
In summary, the variables commonly assessed in pre-surgical evaluation of refractory MTLE-HS are limited to predict the HRQoL determined by QOLIE-31 overall score. The limitations became more evident when these variables were used to predict QOLIE-31 subscale domains. Identification of other variables determining the HRQoL may be important for epilepsy surgery decision-making and post-operative follow-up of patients with refractory MTLE-HS. 
